Stentys amps up Q1 sales; Intuitive pays Luna a $6M milestone;

@FierceMedDev: Stryker's sales jump after string of M&A deals. More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Zimmer buying fellow orthopedics company Biomet for $13.35 billion. | Follow @VarunSaxena2

@EmilyWFierce: Security holes in a number of commonly used medical devices could leave them open to attack. Article | Follow @EmilyWFierce

@MichaelGFierce: ICYMI: DNA nanocages that act like viruses bypass the immune system to deliver drugs. Story | Follow @MichaelGFierce

> French devicemaker Stentys boosted its revenue by 18% in the first quarter, thanks largely to a spike in demand for its self-apposing cardiac stent. Results

> Intuitive Surgical ($ISRG) has handed out another $6 million milestone to Luna Innovations, part of a deal that could pay the company as much as $30 million. More

Biotech News

@FierceBiotech: EuroBiotech Report: GlaxoSmithKline & Novartis reshape EU biotech, Celgene, Hyperion in Euro deals, U.K. cell therapy grows, and more. Report | Follow @FierceBiotech

@JohnCFierce: Pyott told me back in January he could easily spend $10 billion on buyouts. Though that's not Shire territory. Story from January | Follow @JohnCFierce

@DamianFierce: ICYMI: Celgene opens down 5%. Perhaps a $710M deal didn't thrill investors who just watched R&D costs drag profits. | Follow @DamianFierce

@EmilyMFierce: Blood of world's oldest woman hints at limits of life. More | Follow @EmilyMFierce

> Arch Venture swings for a $250M fund to bet on biotechs. Story

> Buyout buzz: Allergan made a pass at Shire before Valeant came calling. Article

> Radius dials up a $92M IPO pitch despite tepid market for biotechs. News

Pharma News

@FiercePharma: Top-read on FiercePharmaManufacturing Thurs: Hospira recalls 7 lots of propofol and one of lidocaine Story | Follow @FiercePharma

@TracyStaton: @Indianmarketeer: Novartis seems to think it can pump up sales of GSK's drugs better than GSK could. But as you say, time will tell. | Follow @TracyStaton

@EricPFierce: A large block of #AstraZeneca shareholders voted against the company's pay plan and one of its directors. More | Follow @EricPFierce

@CarlyHFierce: Arena - Television Ads Raise Awareness. Report from SeekingAlpha | Follow @CarlyHFierce

> Pfizer, Novartis and 3 others put an extra $1M each into Q1 lobbying. Story

> AbbVie's Humira turns in 18% surge in sales. More

> Reuters: Allergan broached deal with Shire before Valeant's hostile bid. Article

Suggested Articles

J&J’s Ethicon unit received an FDA clearance for its Vistaseal applicators that spray a biologic sealant from Grifols to help stem surgical bleeding.

Bio-Techne’s urine test has received a breakthrough device designation from the FDA for ruling out unnecessary tissue biopsies.

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.